Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan.
Clin Exp Immunol. 2013 Aug;173(2):173-8. doi: 10.1111/cei.12131.
We have shown previously that donor-derived splenocytes can replace recipients' bone marrow and induce donor-specific tolerance (DST). We have also shown the usefulness of the chimeric state for the induction of DST. Further analysis of mixed splenocytes chimera, especially the role of each T cells in mixed splenocytes chimera, is indispensable issue for its clinical use. A chimeric state has been shown to achieve long-term survival in major histocompatibility complex (MHC)-mismatched grafts. The donor-derived splenocytes can replace recipients' bone marrow and induce DST. The long-term survival of allogeneic skin grafts was achieved without immunosuppressants. In this study we show the role of each T cell type in a splenocyte mixed chimera. This review provides a short summary of our original work, adding some supplemental interpretations. Mixed chimerism is thus considered an attractive approach for the induction of DST without the use of immunosuppressants. In this paper, we summarize some of the findings on mixed splenocyte chimeras and review mixed chimerism in recent organ transplantation.
我们之前已经证明供体来源的脾细胞可以替代受者的骨髓并诱导供者特异性耐受(DST)。我们还证明了嵌合体状态在诱导 DST 中的有用性。进一步分析混合脾细胞嵌合体,特别是每种 T 细胞在混合脾细胞嵌合体中的作用,对于其临床应用是必不可少的。嵌合体状态已被证明可在主要组织相容性复合物(MHC)不匹配的移植物中实现长期存活。供体来源的脾细胞可以替代受者的骨髓并诱导 DST。无需免疫抑制剂即可实现同种异体皮肤移植物的长期存活。在这项研究中,我们展示了每种 T 细胞类型在脾细胞混合嵌合体中的作用。这篇综述提供了我们原始工作的简短总结,并添加了一些补充解释。因此,混合嵌合体被认为是一种有吸引力的方法,可以在不使用免疫抑制剂的情况下诱导 DST。本文总结了混合脾细胞嵌合体的一些发现,并综述了最近器官移植中的混合嵌合体。